Post Archives

Drs. Elina Liu, Erin Morley, and Anna Rahmani
November 15, 2021

PAUSE Trial & Thrombosis Canada Guidelines: practice tip

Each year, 1 in 6 patients with atrial fibrillation, or an estimated 6 million patients worldwide, will require perioperative anticoagulant management. An increasing number of atrial fibrillation patients are using direct oral anticoagulants (DOACs) in place of warfarin for stroke prevention. However, there has been uncertainty regarding perioperative management of DOACs, with significant variability noted in clinical practice. This can lead to potential harm with an increased risk of thrombosis if a DOAC is held for too long versus increased risk of post-operative bleeding if interruption intervals are too short. read more...

Dr. Elisabeth Baerg Hall
October 27, 2021

Adult ADHD — Practice Tip

October is ADHD Awareness Month. Patients may be increasingly aware of ADHD, having heard about the associated functional impairment and identifying with these stories. Treatment for adults with ADHD is effective. For best results, treatment includes both medications and Executive Function Skills support. read more...

Beata Chami
October 5, 2021

Physician well-being during COVID-19 — burnout & moral injury

It has been eighteen months since COVID-19 emerged in Canada. The trajectory of the pandemic has placed a strain on our citizens’ mental health, particularly our frontline workers. While physician well-being has been a longstanding concern, the global pandemic has magnified the daily challenges that clinicians so bravely navigate to safeguard the health of their patients. read more...

Drs. Lauren Hughes and Heather L. O'Donnell
September 15, 2021

Approach to the patient with flashes and/or floaters

Acute onset of monocular flashes and/or floaters is a common presentation to primary care providers. Most often, this represents a posterior vitreous detachment (PVD), an age-related condition with a prevalence that increases from 24% in adults aged 50 to 59 to 87% among those aged 80 to 89 years. read more...

Jan Klimas, PhD; Michee-Ana Hamilton, MSc; Malcolm Maclure, ScD; Rita McCracken, MD, CCFP, PhD
August 24, 2021

Can we identify patients at risk for Opioid Use Disorder when beginning opioid analgesics for pain from new or ongoing non-cancer causes?

There is growing recognition that opioid prescribing can lead to prescription opioid use disorder (OUD). It is estimated that nearly 115,000 British Columbians have become addicted to opioids. There is a need to safely reduce the volume of new opioid prescriptions for opioid naïve patients. read more...

Shirley Jiang, Edward Tam, and Hin Hin Ko
August 4, 2021

New treatment option for Primary Biliary Cholangitis (PBC)

Primary biliary cholangitis (PBC) is the most common autoimmune liver disease with an incidence of 1 in 1000 in women over age 40. For decades, the only evidence-based treatment was ursodeoxycholic acid. Unfortunately, the rate of inadequate response to UDCA is up to 40%. In 2017, Health Canada approved the use of obeticholic acid (OCA) for the treatment of PBC. UDCA remains first-line therapy for PBC with a long record of use and generic preparations but in non-responders, OCA treatment should be considered. read more...

Dr. Linda Uyeda and Dr. Ashley Miller
July 7, 2021

Curing Through Connection: A 3-part series on attachment, resilience, and health. Article 3: The Importance of Attachment Theory in Healthcare

The ingredients needed to create a happy workplace also largely reflect the principles of secure attachment. Across all levels within organizations, if people do not feel “safe, seen, soothed, and secure” they are more likely to make errors, breach safety protocols, and struggle working together as a team. read more...

Drs. Charles Au, Tristen Gilchrist, and Agnes Lee
June 16, 2021

IMPROVE VTE scoring to guide VTE prophylaxis for medical inpatients

The IMPROVE VTE score is an externally validated tool that can be used to identify low-risk medical patients who do not warrant VTE prophylaxis. read more...

Sue Barlow and Carolyn Rondeau
June 3, 2021

Concussion rehabilitation update and a free self-management concussion tool

Concussions or mild traumatic brain injury are the most common type of traumatic brain injury. It is estimated that every year in British Columbia (BC), there are approximately 14,500 visits to the emergency department and that this number is most likely an underestimate of the “true burden of concussion”. read more...

Dr. Ashley Miller and Dr. Linda Uyeda
May 12, 2021

Curing Through Connection: A 3-part series on attachment, resilience, and health. Article 2: Parenting During a Pandemic

As I started to understand that this pandemic would wear on, I had to figure out how to help my patients’ families and my own family navigate our way through this totally new reality. I drew on the science of attachment, resilience and healthy relationships to make a plan. (Please stay tuned for Article #3!) read more...

Jordan Friedmann, Neda Amiri, Mohammad Bardi, Natasha Dehghan
April 28, 2021

Giant Cell Arteritis Part 2: Treatment

Giant cell arteritis (GCA) is the most common vasculitis in adults above 50 years of age. GCA is a rheumatological emergency. Rapid diagnosis and treatment are required to reduce the risk of complications. read more...

Dr. Colleen Dy, Zerlyn Lee, and Adrienne Sim
April 7, 2021

A Refresher in Pelvic Pain

Individuals with Chronic Pelvic Pain (CPP) often experience disruptions in multiple aspects of their reproductive health care. Routine pelvic examinations often become extremely challenging due to pain. read more...

Dr. Susan Hollenberg
March 17, 2021

Clearing up the confusion around pneumococcal vaccines

It is prudent to reduce the risks of pneumococcal illness during this time of potentially severe respiratory sequelae of COVID-19, and the newly introduced BC Care Bundle Incentive payment includes a focus on ensuring eligible people receive this vaccine. read more...

Dr. Linda Uyeda and Dr. Ashley Miller
March 3, 2021

Curing Through Connection: A 3-part series on attachment, resilience, and health. Article 1: Cultivating secure bonds with our children during stressful times

(Please stay tuned for Article #2: ‘Parenting during a pandemic’. We will expand on how to nurture these secure attachments with our children.) By Dr. Linda Uyeda (biography and disclosures) and Dr. Ashley Miller (biography and disclosures) (Members of the Child and Youth Mental Health and Substance Use Community of Practice and the Working Group […] read more...

Drs. Christopher C. Cheung, Kenneth G. Gin, Jason G. Andrade
February 10, 2021

Rate versus Rhythm Control in Patients with Atrial Fibrillation: Time to Change the Paradigm?

Patients with persistent AF, less symptomatic and/or older patients, and those with prior anti-arrhythmic failure are best managed with a rate control strategy. The EAST-AFNET 4 study is a practice-changing trial, and strongly supports the role of early rhythm control in patients with newly-diagnosed AF. read more...

Drs. Raymond Mak and Tiffany Wong
January 27, 2021

Specialists and Family Practice: Tackling the Pseudo-Penicillin Allergy Epidemic Together

Between 5% to 10% of the population reports an allergy to penicillin. After careful assessment, over 90% of these individuals are found to carry a false allergy label. Having a penicillin allergy label carries many potential harms, including prolonged hospital stays, increased patient costs, risk of more side effects, and an increase in resistant organisms. As such, penicillin allergy has become a major public health concern. read more...

Tanveer Brar BSc BSc(Pharm) ACPR, Doson Chua BSc(Pharm) PharmD FCSHP BCPS BCCP, and Laura Atiyeh
January 13, 2021

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors: New drug class in the treatment of Heart Failure with Reduced Ejection Fraction — DAPA-HF and EMPEROR-Reduced trials

Heart failure (HF) is a clinical syndrome associated with significant morbidity and mortality. In 2020, the prevalence of HF was approximately 64.34 million cases (8.52 per 1,000 inhabitants) worldwide and this number has been steadily increasing over time. There is compelling evidence to suggest that in individuals with HFrEF in the presence or absence of T2DM, both dapagliflozin and empagliflozin have profound effects on reduction of HF hospitalizations and possibly CV mortality. read more...

Dr. Steve Wong
December 23, 2020

Letter from the editor

2020 will go down as the most challenging year on a number of fronts — with unprecedented stressors affecting our personal and professional lives, not to mention the enormous struggles facing our local and global communities. Thanks to everyone on the front lines, and condolences to all those touched by this pandemic. I hope we can continue to work together to beat COVID-19 and I take solace in the fact the turning point seems to be coming as vaccines are deployed. This year also marks This Changed My Practice's 10th year. It's been an incredibly rewarding journey. Given this milestone, I'll indulge in a little bit of history and acknowledgments but also share some of our learnings and future plans. read more...